Previous close | 0.9346 |
Open | 0.9300 |
Bid | 0.9300 x 900 |
Ask | 0.9500 x 4000 |
Day's range | 0.9300 - 0.9500 |
52-week range | 0.8010 - 12.1400 |
Volume | |
Avg. volume | 853,033 |
Market cap | 84.079M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1030 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.25 |
ATLANTA, June 03, 2022--Alzamend Neuro to Present at 12th Annual LD Micro Invitational Investor Conference; Focuses on Progress with Clinical Trials & INDs for AL001 & AL002
ATLANTA, May 17, 2022--Alzamend Neuro Announces Pre-IND Submission for AL001 as a Treatment of Bipolar Disorder, Major Depressive Disorder and Post-Traumatic Stress Disorder
ATLANTA, May 05, 2022--Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s